Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 7
2014 6
2015 2
2016 7
2017 6
2018 5
2019 7
2020 20
2021 11
2022 12
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
Pelizzaro F, Trevisani F, Simeon V, Vitale A, Cillo U, Piscaglia F, Missale G, Sangiovanni A, Foschi FG, Cabibbo G, Caturelli E, Di Marco M, Azzaroli F, Brunetto MR, Raimondo G, Vidili G, Guarino M, Gasbarrini A, Campani C, Svegliati-Baroni G, Giannini EG, Mega A, Masotto A, Rapaccini GL, Magalotti D, Sacco R, Nardone G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Pelizzaro F, et al. Liver Int. 2023 Dec;43(12):2762-2775. doi: 10.1111/liv.15719. Epub 2023 Sep 27. Liver Int. 2023. PMID: 37753540
Targeting T cells in inflammatory bowel disease.
Giuffrida P, Di Sabatino A. Giuffrida P, et al. Pharmacol Res. 2020 Sep;159:105040. doi: 10.1016/j.phrs.2020.105040. Epub 2020 Jun 22. Pharmacol Res. 2020. PMID: 32585338 Review.
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma.
Mosconi C, O'Rourke J, Kloeckner R, Sturm L, Golfieri R, Celsa C, Fateen W, Odisio BC, Garanzini EM, Peck-Radosavljevic M, Borghi A, Ma YT, Stoehr F, Bettinger D, Giuffrida P, Aithal GP, Lin YM, Spreafico C, Giampalma E, Johnson P, Cucchetti A. Mosconi C, et al. Among authors: giuffrida p. Cardiovasc Intervent Radiol. 2023 Apr;46(4):449-459. doi: 10.1007/s00270-023-03375-4. Epub 2023 Feb 27. Cardiovasc Intervent Radiol. 2023. PMID: 36849836
Systemic therapies for hepatocellular carcinoma: the present and the future.
Celsa C, Giuffrida P, Stornello C, Grova M, Spatola F, Rizzo GEM, Busacca A, Cannella R, Battaglia S, Cammà C, Cabibbo G. Celsa C, et al. Among authors: giuffrida p. Recenti Prog Med. 2021 Feb;112(2):110-116. doi: 10.1701/3559.35371. Recenti Prog Med. 2021. PMID: 33624623 Review.
86 results